| Primary |
| Product Used For Unknown Indication |
30.8% |
| Endocarditis Bacterial |
15.4% |
| Abdominal Infection |
7.7% |
| Hypercholesteraemia |
7.7% |
| Infection |
7.7% |
| Off Label Use |
7.7% |
| Staphylococcal Infection |
7.7% |
| Urinary Tract Infection |
7.7% |
| Vaginal Abscess |
7.7% |
|
| Anaphylactic Reaction |
12.5% |
| Myositis |
12.5% |
| Rash Generalised |
12.5% |
| Septic Shock |
12.5% |
| Staphylococcus Test Positive |
12.5% |
| Thrombocytopenia |
12.5% |
| Unresponsive To Stimuli |
12.5% |
| Wrong Technique In Drug Usage Process |
12.5% |
|
| Secondary |
| Infection |
25.7% |
| Drug Use For Unknown Indication |
10.5% |
| Device Related Infection |
9.7% |
| Product Used For Unknown Indication |
9.3% |
| Pseudomonas Infection |
8.4% |
| Sepsis |
3.8% |
| Antibiotic Therapy |
3.4% |
| Neutropenic Sepsis |
3.4% |
| Febrile Neutropenia |
3.0% |
| Immunosuppression |
3.0% |
| Arthritis Infective |
2.5% |
| Multiple Myeloma |
2.5% |
| Non-hodgkin's Lymphoma Stage Iv |
2.5% |
| Meningitis |
2.1% |
| Osteomyelitis |
2.1% |
| Osteomyelitis Bacterial |
2.1% |
| Prophylaxis Against Transplant Rejection |
1.7% |
| Pyrexia |
1.7% |
| Acute Myeloid Leukaemia |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
|
| Multiple-drug Resistance |
15.9% |
| Treatment Failure |
15.9% |
| Sepsis |
9.1% |
| Drug Intolerance |
4.5% |
| Gastrointestinal Hypermotility |
4.5% |
| Myocardial Infarction |
4.5% |
| Refusal Of Treatment By Patient |
4.5% |
| Renal Failure Acute |
4.5% |
| Renal Impairment |
4.5% |
| Septic Shock |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
| Wheezing |
4.5% |
| Clostridium Difficile Colitis |
2.3% |
| Clostridium Difficile Infection |
2.3% |
| Clostridium Test Positive |
2.3% |
| Haemorrhage Intracranial |
2.3% |
| Myopathy |
2.3% |
| Myositis |
2.3% |
| No Therapeutic Response |
2.3% |
| Occult Blood Positive |
2.3% |
|
| Concomitant |
| Acute Myeloid Leukaemia |
17.2% |
| Acute Lymphocytic Leukaemia |
10.0% |
| Multiple Myeloma |
10.0% |
| Renal Transplant |
8.8% |
| Prophylaxis Against Transplant Rejection |
6.5% |
| Liver Transplant |
5.4% |
| Drug Use For Unknown Indication |
5.0% |
| Myelodysplastic Syndrome |
5.0% |
| Diffuse Large B-cell Lymphoma |
4.2% |
| Prophylaxis |
3.8% |
| Antibiotic Therapy |
3.1% |
| Pseudomonas Infection |
3.1% |
| Pulmonary Tuberculosis |
3.1% |
| Stem Cell Transplant |
2.7% |
| Autoimmune Thrombocytopenia |
2.3% |
| Lymphocytic Leukaemia |
2.3% |
| Waldenstrom's Macroglobulinaemia |
2.3% |
| Neurilemmoma Malignant |
1.9% |
| Pneumonia |
1.9% |
| Device Related Infection |
1.5% |
|
| Sepsis |
14.7% |
| Vomiting |
10.8% |
| Thrombocytopenia |
8.8% |
| Respiratory Failure |
5.9% |
| Septic Shock |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Death |
4.9% |
| Unresponsive To Stimuli |
4.9% |
| Tremor |
3.9% |
| Venoocclusive Liver Disease |
3.9% |
| Weight Increased |
3.9% |
| Pneumonia |
2.9% |
| Renal Failure |
2.9% |
| Reperfusion Arrhythmia |
2.9% |
| Respiratory Distress |
2.9% |
| Right Ventricular Failure |
2.9% |
| Shock |
2.9% |
| Staphylococcal Infection |
2.9% |
| Toxicity To Various Agents |
2.9% |
| Varicose Vein |
2.9% |
|
